RXRX
Recursion Pharmaceuticals, Inc.Healthcare$3.11
▲ Bullish
Mkt Cap: $1.64B|Float: 510.3M|SI: 34.1%|DTC: 9.8
Data as of market close Apr 2, 2026
IV Rank
49
IV Pctl
56%
HV 20d
47.4%
52W Range
$3-$7
ATR(14)
$0.18
Exp. Move
±7.9%
P/C Ratio
0.19
Earnings
May 5
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Above
Exp. Move Wide
Low Put/Call
RXRX Key Options Data
- IV Rank
- 48.5%
- Total GEX
- $0.01B
- Total DEX
- $7.2M
- Max Pain
- $3.50
- Expected Move
- ±7.9%
- Put/Call OI
- 0.19
- Net Premium
- $-0.5M
- Spot Price
- $3.11
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$0.24 | ±7.9% | $2.86 | $3.35 |
| 2026-04-17 | 15 | ±$0.34 | ±11.1% | $2.76 | $3.45 |
| 2026-04-24 | 22 | ±$0.35 | ±11.4% | $2.75 | $3.46 |
| 2026-05-01 | 29 | ±$0.68 | ±21.9% | $2.43 | $3.79 |
| 2026-05-15 | 43 | ±$0.69 | ±22.0% | $2.42 | $3.79 |
| 2026-06-18 | 77 | ±$0.94 | ±30.2% | $2.17 | $4.05 |
Explore RXRX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.